People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 supplements.
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.
The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...
The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures ...
Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday.Invest with Confidence: ...
Dr. Jeffrey K. Moore and West Clinical Research are proud to announce the grand opening of their new clinical research site, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback